7-Cyano-7-deazaguanine

CAS No. 69205-79-4

7-Cyano-7-deazaguanine ( 7-CN-7-deazaG )

Catalog No. M29549 CAS No. 69205-79-4

3H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 2-amino-4,7-dihydro-4-oxo- is a marine derived natural products found in Streptomyces qinglanensis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    7-Cyano-7-deazaguanine
  • Note
    Research use only, not for human use.
  • Brief Description
    3H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 2-amino-4,7-dihydro-4-oxo- is a marine derived natural products found in Streptomyces qinglanensis.
  • Description
    3H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 2-amino-4,7-dihydro-4-oxo- is a marine derived natural products found in Streptomyces qinglanensis.
  • Synonyms
    7-CN-7-deazaG
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    69205-79-4
  • Formula Weight
    175.2
  • Molecular Formula
    C7H5N5O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#CC1=CNC=2NC(=NC(=O)C12)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pyrantel tartrate

    Pyrantel tartrate is an antinematodal thiophene; and can elicit spastic muscle paralysis in parasitic worms due to prolonged activation of the excitatory nicotinic acetylcholine (nACh) receptors on body wall muscle.

  • Glycyl-L-valine

    Glycyl-L-valine is a dipeptide composed of glycine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism.

  • 3-Hydroxy-2-methylpy...

    3-Hydroxy-2-methylpyridine could as a promising molecular scaffold for the future development of novel fibrillization inhibitors.